Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease
Melanie Ricke‐Hoch(Medizinische Hochschule Hannover), Denise Hilfiker‐Kleiner(Medizinische Hochschule Hannover)
Cited by 89
Related Papers
Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
|European Journal of Heart Failure|2010|1.1k
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies
|New England Journal of Medicine|2016|597
Pathophysiology, Diagnosis and Management of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy
|European Journal of Heart Failure|2019|435
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy
|Basic Research in Cardiology|2013|351
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study
|European Heart Journal|2017|334